Skip to Main Content

Paper Details

Budesonide delayed-release capsules to reduce proteinuria in adults with primary immunoglobulin A nephropathy.
Expert Rev Clin Immunol
1
2023
Budesonide, Gd, Gd-IgA1, IgAN, Immunoglobulin A nephropathy, Nefecon, budesonide, galactose, galactose-deficient IgA1, immunoglobulin A, mucosally, mucosally sited B cells, patients, primary immunoglobulin A nephropathy, proteinuria
Author NameAffiliation
Brad H RovinThe Ohio State University Wexner Medical Center
Brad H RovinThe Ohio State University Wexner Medical Center
  • 1 - 2

Datasets

Release 1.2